Literature DB >> 19561782

Myopic traction maculopathy: study with spectral domain optical coherence tomography and review of the literature.

V Konidaris1, S Androudi, P Brazitikos.   

Abstract

AIM: To describe the tomographic findings of a case of myopic traction maculopathy using Spectral Domain Optical Coherence Tomography (SD-OCT) and present the results of its surgical intervention.
DESIGN: Observational case report and review of the literature.
METHODS: A 61-year-old male with metamorphopsia was examined clinically and with the use of SD-OCT. The diagnosis of myopic traction maculopathy was made. The patient underwent pars plana vitrectomy with removal of the vitreomacular adhesions, the epiretinal and the internal limiting membrane.
RESULTS: Visual acuity increased by two Snellen lines, metamorphopsia disappeared, macular morphology was improved and myopic traction maculopathy was resolved.
CONCLUSIONS: Imaging with SD-OCT is capable of documentation and measurement of the early stages of myopic traction maculopathy. Moreover, vitrectomy was beneficial for the visual and anatomic outcome of the patient.

Entities:  

Keywords:  myopic traction maculopathy; spectral domain optical coherence tomography

Year:  2009        PMID: 19561782      PMCID: PMC2683149     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  10 in total

1.  Pathologic myopia: where are we now?.

Authors:  Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

2.  Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study.

Authors:  Y-F Shih; T-C Ho; C K Hsiao; L L-K Lin
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

3.  Vitrectomy and gas tamponade without internal limiting membrane peeling for myopic foveoschisis.

Authors:  A K H Kwok; T Y Y Lai; W W K Yip
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 4.  Epidemiology of myopia.

Authors:  S M Saw; J Katz; O D Schein; S J Chew; T K Chan
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

5.  Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma.

Authors:  M Takano; S Kishi
Journal:  Am J Ophthalmol       Date:  1999-10       Impact factor: 5.258

6.  Retinal detachment associated with a macular hole in severely myopic eyes.

Authors:  J Akiba; S Konno; A Yoshida
Journal:  Am J Ophthalmol       Date:  1999-11       Impact factor: 5.258

7.  Macular retinoschisis in highly myopic eyes.

Authors:  Nathanaël Benhamou; Pascale Massin; Belkacem Haouchine; Ali Erginay; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2002-06       Impact factor: 5.258

8.  Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis.

Authors:  Hideo Kobayashi; Shoji Kishi
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

9.  Optical coherence tomography findings in myopic traction maculopathy.

Authors:  Giacomo Panozzo; Andrea Mercanti
Journal:  Arch Ophthalmol       Date:  2004-10

10.  Vitrectomy for myopic traction maculopathy.

Authors:  Giacomo Panozzo; Andrea Mercanti
Journal:  Arch Ophthalmol       Date:  2007-06
  10 in total
  3 in total

1.  Diagnosis and treatment of myopic traction maculopathy.

Authors:  Ping-Bo Ouyang; Xuan-Chu Duan; Xiao-Hua Zhu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

2.  A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).

Authors:  Peter Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-22       Impact factor: 3.117

3.  Multimodal Imaging-Based Phenotyping of a Singaporean Hospital-Based Cohort of High Myopia Patients.

Authors:  Kai Yuan Tey; Quan V Hoang; Isabella Q Loh; Yee Shan Dan; Qiu Ying Wong; Daryle Jason G Yu; Vivi R Yandri; Marcus Ang; Gemmy C M Cheung; Shu Yen Lee; Tien Yin Wong; Rachel S Chong; Chee Wai Wong
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.